A Culture Of Quality

Each professional laboratory should have an own developed work system. This system should be based on both written and unwritten rules that the laboratory encourages its employees to follow them. The development of the quality system, with the underlying documentation, can change the rules described relatively easily. However, it is much more difficult to change unwritten rules and create the expected quality system culture for all employees.

A safety assessment is only as good as the data supporting it. It is necessary therefore to verify the scientific integrity of all components of an assessment. The biocompatibility tests of medical devices have to be performed in laboratories with appropriate accreditations (ISO 17025) and / or certificates (Good Laboratory Practice – GLP).

Additionally, in order to implement a medical device in some markets, it is necessary to have documentation in accordance with the requirements of appropriate Competent Authorities. For example, USA (FDA), Korea (MFDS) or Brazil (ANVISA) are respected only the results of biocompatibility tests performed in GLP-certified Test Facilities.


European Biological Institute is Good Laboratory Practice (GLP) certified and ISO 17025 accredited
. Thanks to this, our laboratories guarantee the reliability of the biocompatibility tests of medical devices and give the opportunity to strengthen the position on world markets in according to the principle of “tested or certified once – accepted everywhere”.

For further information, please contact your sales representative team if you’re an existing customer or if you’re new to European Biological Institute please reach us at contact@ebi.bio or visit our website !

We look forward to helping you reach all of your evaluation goals and a successful submission!
We are here to support you!

See more

ISO 10993-1:2025: Enhanced Characterization, Clearer Risk Logic

The 2025 revision keeps biological evaluation firmly inside ISO 14971 risk management and across the full device life cycle. Your…

ISO 10993-1:2025: Risk Management Integration and Exposure Duration

ISO 10993-1:2025 embeds the biological evaluation within ISO 14971’s risk-management framework. The standard explicitly requires identifying biological hazards, estimating their…

Preparing for Biocompatibility Testing: Strategic Considerations for Medical Device Manufacturers

Biocompatibility testing is essential for every medical device, ensuring safety, regulatory approval, and market success. The process, however, can be…

In Vitro & In Vivo: Strategic Insights for Medical Device Leaders

Biocompatibility testing is not just a regulatory requirement—it is a cornerstone of medical device safety, market approval, and long-term trust….

Biocompatibility Requirements for Wearable Medical Devices: Unique Considerations

Wearable medical devices are transforming healthcare with continuous monitoring, real-time diagnostics, and improved patient engagement. However, their design introduces distinct…

Proactive Planning: Combining Biocompatibility with Other Preclinical Testing Needs

Biocompatibility testing is a vital part of preclinical evaluation, but it’s just one piece of the larger puzzle. Manufacturers often…